- Home
- IPDN vs AIDX Comparison
IPDN vs AIDX Comparison
Compare IPDN & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPDN | AIDX |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 6.7M |
| IPO Year | 2012 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IPDN | AIDX |
|---|---|---|
| Price | $0.22 | $0.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 581.5K | 93.0K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,054,219.00 | $2,045,133.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.20 | $0.40 |
| 52 Week High | $12.39 | $14.09 |
Technical Indicators
Market Signals| Indicator | IPDN | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 29.37 | 55.03 |
| Support Level | N/A | $0.52 |
| Resistance Level | $0.46 | $0.57 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 11.06 | 79.40 |
Price Performance
Historical ComparisonAbout IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.